IN168119B - - Google Patents

Info

Publication number
IN168119B
IN168119B IN837/CAL/87A IN837CA1987A IN168119B IN 168119 B IN168119 B IN 168119B IN 837CA1987 A IN837CA1987 A IN 837CA1987A IN 168119 B IN168119 B IN 168119B
Authority
IN
India
Application number
IN837/CAL/87A
Other languages
English (en)
Inventor
Dieter Sauerbier
Uwe Peter Dammann
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of IN168119B publication Critical patent/IN168119B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Amplifiers (AREA)
IN837/CAL/87A 1986-10-31 1987-10-26 IN168119B (enrdf_load_html_response)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (1)

Publication Number Publication Date
IN168119B true IN168119B (enrdf_load_html_response) 1991-02-09

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
IN837/CAL/87A IN168119B (enrdf_load_html_response) 1986-10-31 1987-10-26

Country Status (25)

Country Link
EP (1) EP0265812B1 (enrdf_load_html_response)
JP (1) JPS63159319A (enrdf_load_html_response)
KR (1) KR900003491B1 (enrdf_load_html_response)
AT (1) ATE55250T1 (enrdf_load_html_response)
AU (1) AU598602B2 (enrdf_load_html_response)
CA (1) CA1314231C (enrdf_load_html_response)
DD (1) DD262582A5 (enrdf_load_html_response)
DE (1) DE3764235D1 (enrdf_load_html_response)
DK (1) DK169308B1 (enrdf_load_html_response)
EG (1) EG18333A (enrdf_load_html_response)
ES (1) ES2017982B3 (enrdf_load_html_response)
FI (1) FI87140C (enrdf_load_html_response)
GE (1) GEP19971025B (enrdf_load_html_response)
GR (1) GR3000708T3 (enrdf_load_html_response)
HU (1) HU197987B (enrdf_load_html_response)
IL (1) IL84312A (enrdf_load_html_response)
IN (1) IN168119B (enrdf_load_html_response)
LV (1) LV10051B (enrdf_load_html_response)
MX (1) MX8958A (enrdf_load_html_response)
NO (1) NO873860L (enrdf_load_html_response)
PT (1) PT86032B (enrdf_load_html_response)
RU (1) RU1836079C (enrdf_load_html_response)
UA (1) UA11075A (enrdf_load_html_response)
YU (1) YU197387A (enrdf_load_html_response)
ZA (1) ZA878183B (enrdf_load_html_response)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE65402T1 (de) * 1988-03-19 1991-08-15 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
ES2253877T3 (es) * 1998-03-03 2006-06-01 SHIONOGI & CO., LTD. Composiciones farmaceuticas que contienen el inhibidor de fosfolipasa((3-(2-amino-1,2-dioxoetil)-2-etil-1-(fenilmetil)-1h-indol-4-il)oxi)acetato de sodio.
CA2497898C (en) * 2002-09-05 2012-02-07 Bharat Serums & Vaccines Ltd. Liquid stable composition of oxazaphosphorine with mesna
EP1569663B1 (en) * 2002-12-02 2010-04-28 Bharat Serums & Vaccines Ltd. Ifosfamide compositions for parenteral administration and a process for their preparation
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
BRPI0715279A2 (pt) * 2006-09-29 2013-06-11 Infa Sa sistema de embalagem, sistema de embalagem para uma composiÇço farmacÊutica, mÉtodo para transferir uma composiÇço farmcÊutica para administraÇço por infusço intravenosa, uso de um sistema de embalagem, kit para administraÇço parenteral de fÁrmacos com um acesso intravenoso e kit admnistraÇço parenteral de princÍpios ativos
CN105900385B (zh) * 2014-12-04 2019-08-27 华为技术有限公司 在数据通信网中的负载分配

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
DE3279834D1 (en) * 1981-12-31 1989-08-31 Asta Pharma Ag 4-sulfido-oxaza phosphorines and their use in the treatment of cancer, and in immunosuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
GEP19971025B (en) 1997-04-06
DD262582A5 (de) 1988-12-07
DK569687A (da) 1988-05-01
DK569687D0 (da) 1987-10-30
FI87140C (fi) 1992-12-10
FI87140B (fi) 1992-08-31
CA1314231C (en) 1993-03-09
JPH0543684B2 (enrdf_load_html_response) 1993-07-02
FI874727A0 (fi) 1987-10-27
HUT44932A (en) 1988-05-30
YU197387A (en) 1988-12-31
PT86032A (de) 1987-11-01
ES2017982B3 (es) 1991-03-16
NO873860D0 (no) 1987-09-15
JPS63159319A (ja) 1988-07-02
EG18333A (en) 1993-12-30
FI874727L (fi) 1988-05-01
DE3764235D1 (de) 1990-09-13
DK169308B1 (da) 1994-10-10
LV10051A (lv) 1994-05-10
NO873860L (no) 1988-05-02
HU197987B (en) 1989-07-28
ZA878183B (en) 1988-05-02
KR880004814A (ko) 1988-06-27
IL84312A0 (en) 1988-03-31
GR3000708T3 (en) 1991-10-10
EP0265812B1 (de) 1990-08-08
KR900003491B1 (ko) 1990-05-21
AU598602B2 (en) 1990-06-28
LV10051B (en) 1995-06-20
IL84312A (en) 1991-11-21
PT86032B (pt) 1990-08-31
RU1836079C (ru) 1993-08-23
MX8958A (es) 1993-12-01
AU8052987A (en) 1988-05-05
UA11075A (uk) 1996-12-25
EP0265812A1 (de) 1988-05-04
ATE55250T1 (de) 1990-08-15

Similar Documents

Publication Publication Date Title
AU7131891A (enrdf_load_html_response)
IN168119B (enrdf_load_html_response)
AU7354491A (enrdf_load_html_response)
AU6562586A (enrdf_load_html_response)
AU7131791A (enrdf_load_html_response)
AU6014586A (enrdf_load_html_response)
AU5878886A (enrdf_load_html_response)
AU5480786A (enrdf_load_html_response)
AU5537386A (enrdf_load_html_response)
AU5597686A (enrdf_load_html_response)
AU5614386A (enrdf_load_html_response)
AU5344086A (enrdf_load_html_response)
AU5644686A (enrdf_load_html_response)
AU5655786A (enrdf_load_html_response)
AU5684886A (enrdf_load_html_response)
AU5703286A (enrdf_load_html_response)
AU5724586A (enrdf_load_html_response)
AU5745586A (enrdf_load_html_response)
AU5130385A (enrdf_load_html_response)
AU5857886A (enrdf_load_html_response)
AU5227086A (enrdf_load_html_response)
AU5940986A (enrdf_load_html_response)
AU5982886A (enrdf_load_html_response)
AU6011386A (enrdf_load_html_response)
AU4910985A (enrdf_load_html_response)